Proglumetacin
Appearance
Structure of proglumetacin | ||
Structures of the two metabolites | ||
| Clinical data | ||
|---|---|---|
| Trade names | Afloxan, Protaxon, Proxil | |
| Other names | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate | |
| AHFS/Drugs.com | International Drug Names | |
| ATC code | ||
| Pharmacokinetic data | ||
| Metabolism | Hepatic. Undergoes enterohepatic recirculation | |
| Identifiers | ||
| ||
| CAS Number | ||
| PubChem CID | ||
| ChemSpider | ||
| UNII | ||
| ChEBI | ||
| CompTox Dashboard (EPA) | ||
| Chemical and physical data | ||
| Formula | C46H58ClN5O8 | |
| Molar mass | 844.45 g·mol−1 | |
| 3D model (JSmol) | ||
| ||
| ||
| (verify) |
Proglumetacin (usually supplied as the maleate salt) is a nonsteroidal anti-inflammatory drug (NSAID). It is a codrug (that is, a mutual prodrug) of indometacin and proglumide.[1] After oral intake, it is absorbed and metabolized to indometacin and proglumide. These two substances are then released into the system in a 1:1 molar ratio.
Indometacin contributes to the anti-inflammatory effect, while proglumide has antisecretory effects that helps prevent injury to the stomach lining.